- Report
- April 2023
- 110 Pages
Global
From €4270EUR$4,750USD£3,706GBP
- Report
- October 2022
- 70 Pages
Africa
From €4270EUR$4,750USD£3,706GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4270EUR$4,750USD£3,706GBP
- Report
- February 2024
- 75 Pages
Canada
From €4270EUR$4,750USD£3,706GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4270EUR$4,750USD£3,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4270EUR$4,750USD£3,706GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4270EUR$4,750USD£3,706GBP
- Report
- February 2024
- 70 Pages
Australia
From €4270EUR$4,750USD£3,706GBP
- Report
- August 2023
- 112 Pages
North America
From €4270EUR$4,750USD£3,706GBP
- Report
- August 2023
- 90 Pages
North America
From €4270EUR$4,750USD£3,706GBP
- Report
- August 2023
- 70 Pages
Europe
From €4270EUR$4,750USD£3,706GBP
- Report
- July 2025
- 200 Pages
India
From €2507EUR$2,789USD£2,176GBP
- Report
- June 2025
- 250 Pages
Canada
From €2507EUR$2,789USD£2,176GBP
- Report
- August 2024
- 150 Pages
Global
From €2507EUR$2,789USD£2,176GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3478EUR$3,869USD£3,019GBP
- Report
- May 2023
- 160 Pages
Global
From €4448EUR$4,949USD£3,862GBP
- Report
- May 2023
- 147 Pages
Global
From €4448EUR$4,949USD£3,862GBP
- Report
- March 2026
- 136 Pages
France
From €3595EUR$3,999USD£3,120GBP
- Report
- February 2026
- 149 Pages
Canada
From €3595EUR$3,999USD£3,120GBP
- Report
- July 2024
- 138 Pages
Japan
From €3595EUR$3,999USD£3,120GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more